IBDEI0I4 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8772,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,8772,2)
 ;;=^88172
 ;;^UTILITY(U,$J,358.3,8773,0)
 ;;=368.13^^52^586^41
 ;;^UTILITY(U,$J,358.3,8773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8773,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,8773,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,8773,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,8774,0)
 ;;=998.59^^52^586^42
 ;;^UTILITY(U,$J,358.3,8774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8774,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,8774,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,8774,2)
 ;;=^97081
 ;;^UTILITY(U,$J,358.3,8775,0)
 ;;=368.03^^52^586^5
 ;;^UTILITY(U,$J,358.3,8775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8775,1,3,0)
 ;;=3^Amblyopia,Refractive
 ;;^UTILITY(U,$J,358.3,8775,1,4,0)
 ;;=4^368.03
 ;;^UTILITY(U,$J,358.3,8775,2)
 ;;=^265363
 ;;^UTILITY(U,$J,358.3,8776,0)
 ;;=367.31^^52^586^6
 ;;^UTILITY(U,$J,358.3,8776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8776,1,3,0)
 ;;=3^Anisometropia
 ;;^UTILITY(U,$J,358.3,8776,1,4,0)
 ;;=4^367.31
 ;;^UTILITY(U,$J,358.3,8776,2)
 ;;=^7839
 ;;^UTILITY(U,$J,358.3,8777,0)
 ;;=367.20^^52^586^7
 ;;^UTILITY(U,$J,358.3,8777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8777,1,3,0)
 ;;=3^Astigmatism,NOS
 ;;^UTILITY(U,$J,358.3,8777,1,4,0)
 ;;=4^367.20
 ;;^UTILITY(U,$J,358.3,8777,2)
 ;;=^11141
 ;;^UTILITY(U,$J,358.3,8778,0)
 ;;=367.0^^52^586^31
 ;;^UTILITY(U,$J,358.3,8778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8778,1,3,0)
 ;;=3^Hypermetropia
 ;;^UTILITY(U,$J,358.3,8778,1,4,0)
 ;;=4^367.0
 ;;^UTILITY(U,$J,358.3,8778,2)
 ;;=^60139
 ;;^UTILITY(U,$J,358.3,8779,0)
 ;;=367.1^^52^586^37
 ;;^UTILITY(U,$J,358.3,8779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8779,1,3,0)
 ;;=3^Myopia
 ;;^UTILITY(U,$J,358.3,8779,1,4,0)
 ;;=4^367.1
 ;;^UTILITY(U,$J,358.3,8779,2)
 ;;=^80671
 ;;^UTILITY(U,$J,358.3,8780,0)
 ;;=V43.1^^52^586^45
 ;;^UTILITY(U,$J,358.3,8780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8780,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,8780,1,4,0)
 ;;=4^V43.1
 ;;^UTILITY(U,$J,358.3,8780,2)
 ;;=^69114
 ;;^UTILITY(U,$J,358.3,8781,0)
 ;;=367.9^^52^586^46
 ;;^UTILITY(U,$J,358.3,8781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8781,1,3,0)
 ;;=3^Refractive Error
 ;;^UTILITY(U,$J,358.3,8781,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,8781,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,8782,0)
 ;;=365.04^^52^586^26
 ;;^UTILITY(U,$J,358.3,8782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8782,1,3,0)
 ;;=3^Glaucoma Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,8782,1,4,0)
 ;;=4^365.04
 ;;^UTILITY(U,$J,358.3,8782,2)
 ;;=^85124
 ;;^UTILITY(U,$J,358.3,8783,0)
 ;;=365.01^^52^586^30
 ;;^UTILITY(U,$J,358.3,8783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8783,1,3,0)
 ;;=3^Glaucoma Suspect
 ;;^UTILITY(U,$J,358.3,8783,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,8783,2)
 ;;=^340633
 ;;^UTILITY(U,$J,358.3,8784,0)
 ;;=365.71^^52^586^24
 ;;^UTILITY(U,$J,358.3,8784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8784,1,3,0)
 ;;=3^Glaucoma Mild Stage
 ;;^UTILITY(U,$J,358.3,8784,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,8784,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,8785,0)
 ;;=365.72^^52^586^25
 ;;^UTILITY(U,$J,358.3,8785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8785,1,3,0)
 ;;=3^Glaucoma Moderate Stage
 ;;^UTILITY(U,$J,358.3,8785,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,8785,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,8786,0)
 ;;=365.73^^52^586^28
 ;;^UTILITY(U,$J,358.3,8786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8786,1,3,0)
 ;;=3^Glaucoma Severe Stage
 ;;^UTILITY(U,$J,358.3,8786,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,8786,2)
 ;;=^340515
